The Efficacy of Thread Embedding Acupuncture on Pain Score, Neck Disability Index, and Pressure Pain Threshold for Myofascial Pain Therapy in the Upper Trapezius Muscle
1 other identifier
interventional
44
1 country
2
Brief Summary
Myofascial pain is characterized by myofascial trigger points, considered as a major cause of neck and shoulder pain in the working population. Thread-embedding acupuncture is a new acupuncture modality that can provide long-term stimulation aimed at prolonging its therapeutic effect that is similar to conventional acupuncture, such as analgesic effects. The goal of this randomized controlled trial is to evaluate and compare the effects of thread-embedding acupuncture and sham thread-embedding acupuncture as a therapy for myofascial pain in the upper trapezius muscle. The primary aim of this study is to investigate whether thread-embedding acupuncture therapy gives better and last longer results for myofascial pain of the upper trapezius muscle than sham thread-embedding acupuncture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
August 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedDecember 27, 2023
December 1, 2023
2 months
July 26, 2023
December 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Visual Analog Scale
Pain rating scale for measuring pain
before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment
Secondary Outcomes (2)
Neck Disability Index
before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment
Pressure Pain Threshold
before treatment (baseline) and 3 days, 1 week, 4 weeks, 8 weeks after treatment
Study Arms (2)
Thread-Embedding Acupuncture
EXPERIMENTALThread-Embedding Acupuncture using a 29-gauge TEA needle with a 50-mm PDO (polydioxanone) thread
Sham Thread-Embedding Acupuncture
SHAM COMPARATORSham Thread-Embedding Acupuncture using a 29-gauge TEA needle but thread-removed, just needle alone
Interventions
Thread-Embedding Acupuncture: using a 29-gauge TEA needle with a 50-mm PDO (polydioxanone) thread Sham Thread-Embedding Acupuncture: using a 29-gauge TEA needle but thread-removed, just needle alone
Eligibility Criteria
You may qualify if:
- Male or female aged 18-59 years.
- Subject with myofascial pain in the upper trapezius muscle.
- VAS score of 30-70 mm from 100 mm during activities (everyday activities or light exercise).
- Pain \> 3 months.
- Willing to participate in this research to completion and sign informed consent.
You may not qualify if:
- Fibromyalgia.
- Have had cervical spine surgery.
- Have done Dry needling therapy on the upper trapezius muscle in the last 9 days
- Have done thread acupuncture on the upper trapezius muscle in the last 6 months.
- Have performed pharmacopuncture on the upper trapezius muscle in the last 6 months.
- VAS score is more than 70 mm than 100 mm at resting.
- History of anti-inflammatory drug treatment in the previous 2 weeks.
- History of intra-articular steroid injections in the previous 3 months.
- There is a tumor, wound, or skin infection at the needle insertion area.
- Fever (≥ 37.5 oC).
- There is a hypersensitivity reaction in previous acupuncture therapy (metal allergy, severe atopy, keloids, or other skin hypersensitivity).
- Suffering from a blood disorder or taking blood thinners (anti-platelet or anti-coagulant drugs).
- Have a heart condition or uncontrolled diabetes.
- Blood glucose level (GDS) ≥200 mg/dL is checked by capillary blood using a glucometer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cipto Mangunkusumo Hospital
Jakarta, DKI Jakarta, 10430, Indonesia
Persahabatan Hospital
Jakarta, DKI Jakarta, 13230, Indonesia
Study Officials
- PRINCIPAL INVESTIGATOR
KEPK FKUI-RSCM
The Ethics Committee of the Faculty of Medicine, University of Indonesia - Cipto Mangunkusumo Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
July 26, 2023
First Posted
August 14, 2023
Study Start
August 21, 2023
Primary Completion
October 31, 2023
Study Completion
October 31, 2023
Last Updated
December 27, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL